Embryonic/fetal cell transplantation for Parkinson's disease
HAYES, Inc.
Record ID 32006000095
English
Authors' objectives:
Human or xenogeneic embryonic/fetal cell transplantation was introduced for the treatment of Parkinson's disease (PD) with the goal that embryonic or fetal dopaminergic neuronal cells would regenerate the damaged neuronal tissue in patients with PD, thereby reducing their symptoms and/or slowing disease progression.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com/
Year Published:
2005
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Fetal Tissue Transplantation
- Parkinson Disease
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.